Literature DB >> 18801938

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for the Use of Tumor Markers.

Eleftherios P Diamandis1, Barry R Hoffman, Catharine M Sturgeon.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18801938     DOI： 10.1373/clinchem.2008.105494

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  15 in total

Review 1.  Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application.

Authors:  Zhen Zhao; Jia Fan; Yen-Michael S Hsu; Christopher J Lyon; Bo Ning; Tony Y Hu
Journal:  Lab Chip       Date:  2019-03-27       Impact factor: 6.799

Review 2.  Obstacles to precision oncology: confronting current factors affecting the successful introduction of biomarkers to the clinic.

Authors:  Ludmila Prudkin; Paolo Nuciforo
Journal:  Cell Oncol (Dordr)       Date:  2014-09-04       Impact factor: 6.730

3.  Cancer biomarkers: can we turn recent failures into success?

Authors:  Eleftherios P Diamandis
Journal:  J Natl Cancer Inst       Date:  2010-08-12       Impact factor: 13.506

4.  Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer.

Authors:  Fan Sun; Yu-Ao Tan; Qiu-Fang Gao; Shu-Qi Li; Jing Zhang; Qing-Gen Chen; Yu-Huan Jiang; Lei Zhang; Hou-Qun Ying; Xiao-Zhong Wang
Journal:  J Clin Lab Anal       Date:  2018-07-25       Impact factor: 2.352

5.  Development and validation of a novel diagnostic model for assessing lung cancer metastasis in a Chinese population based on multicenter real-world data.

Authors:  Yiyong Yao; Cunling Yan; Wei Zhang; San-Gang Wu; Jie Guan; Gang Zeng; Qiang Du; Chun Huang; Hui Zhang; Huiling Wang; Yanfeng Hou; Zhiyan Li; Lixin Wang; Yijie Zheng; Xun Li
Journal:  Cancer Manag Res       Date:  2019-10-29       Impact factor: 3.989

6.  The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?

Authors:  Eleftherios P Diamandis
Journal:  BMC Med       Date:  2012-08-09       Impact factor: 8.775

7.  Development of a Chemiluminescence Immunoassay for Serum YB-1 and its Clinical Application as a Potential Diagnostic Marker for Hepatocellular Carcinoma.

Authors:  Li Pu; Shi Jing; Guo Bianqin; Liu Ping; Liang Qindong; Liu Chenggui; Cheng Feng; Kuang Wenbin; Wang Qin; Dong Jinyu; Xia Qianfeng; Liu Yu; Tu Zhiguang
Journal:  Hepat Mon       Date:  2013-07-03       Impact factor: 0.660

Review 8.  Resolving breast cancer heterogeneity by searching reliable protein cancer biomarkers in the breast fluid secretome.

Authors:  Ferdinando Mannello; Daniela Ligi
Journal:  BMC Cancer       Date:  2013-07-12       Impact factor: 4.430

Review 9.  Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box.

Authors:  Caterina Marchiò; Mitch Dowsett; Jorge S Reis-Filho
Journal:  BMC Med       Date:  2011-04-19       Impact factor: 8.775

10.  Towards identification of true cancer biomarkers.

Authors:  Eleftherios P Diamandis
Journal:  BMC Med       Date:  2014-09-11       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.